Results 31 to 40 of about 8,106 (209)

Medical Adjuvant Therapy in Reducing Thrombosis With Arteriovenous Grafts and Fistulae Use: A Meta-Analysis of Randomized Controlled Trials

Clinical and Applied Thrombosis/Hemostasis, 2021
Hemodialysis is required for patients with end-stage renal disease (ESRD) that require arteriovenous (AV) grafts or fistulas for vascular access. These access points are prone to thrombosis. To determine the effect of medical adjuvant therapy on AV graft/
Kaleem Ullah MBBS, Maham Bashir MBBS, Noor Ul Ain MBBS, Azza Sarfraz MBBS, Zouina Sarfraz MBBS, Muzna Sarfraz MBBS, Ivan Cherrez-Ojeda MD, MSc   +6 more
doaj   +1 more source

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?

Current Controlled Trials in Cardiovascular Medicine, 2000
The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events trial ...
Algra Ale, van Gijn Jan
doaj   +1 more source

Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis. [PDF]

PLoS ONE, 2015
There is a lack of consensus regarding which type of antiplatelet agent should be used in patients with peripheral arterial disease (PAD) and little is known on the advantages and disadvantages of dual antiplatelet therapy.
Konstantinos Katsanos, Stavros Spiliopoulos, Prakash Saha, Athanasios Diamantopoulos, Narayan Karunanithy, Miltiadis Krokidis, Bijan Modarai, Dimitris Karnabatidis   +7 more
doaj   +1 more source

Incidence of neutropenia in patients with ticlopidine/Ginkgo biloba extract combination drug for vascular events: A post-marketing cohort study.

PLoS ONE, 2019
Background and purposeThe ticlopidine/Ginkgo biloba ext. combination drug (Yuclid) is used as an antiplatelet agent for prevention of vascular events since its approval in 2008.
Han-Gil Jeong, Jae Sun Yoon, Juneyoung Lee, Hee-Joon Bae   +3 more
doaj   +1 more source

Antinuclear Antibody-Positive Ticlopidine-Induced Hepatitis

Canadian Journal of Gastroenterology, 1996
Ticlopidine hydrochloride has been shown to reduce the risk of first or recurrent stroke in patients who have experienced a transient ischemic attack, reversible ischemic neurological deficit, recurrent stroke or first stroke. Severe liver dysfunction is
Sander Jo Veldhuyzen van Zanten, C William McCormick   +1 more
doaj   +1 more source

Antiaggregant therapy in neurological practice: objectives and possibilities

Неврология, нейропсихиатрия, психосоматика, 2010
Based on the data available in the literature, the authors consider the prevention of ischemic stroke and other cardiovascular diseases in high-risk group patients.
E. V. Portnyagina, A. F. Portnyagin
doaj   +1 more source

Warfarin interactions: a letter to editor [PDF]

Patient Safety and Quality Improvement Journal, 2019
Today, with the advances in the treatment of cardiovascular patients such as intravascular stents, cardiac valves and intraventricular pacing and heart transplantation, many patients require the use of anticoagulants such as warfarin, sprain, Plavix ...
Sayyed Majid Sadrzadeh, Elnaz Vafadar Moradi, Seyed Mohammad Mousavi, Behrang Rezvani Kakhki, Shaghayegh Rahmani   +4 more
doaj   +1 more source

Safety of edoxaban for delayed bleeding in gastrointestinal endoscopic procedures with a high risk of bleeding

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Objectives There are limited reports on the safety of gastrointestinal endoscopic procedures in individuals taking edoxaban, one of the direct oral anticoagulants. We clarified the incidence of delayed bleeding in patients who were on edoxaban in the perioperative period of gastrointestinal endoscopic procedures with a high risk of bleeding ...
Ken‐ichi Mizuno, Junji Yokoyama, Osamu Shibata, Yuichi Kojima, Yuzo Kawata, Kazuya Takahashi, Kentaro Tominaga, Ikarasi Satoshi, Hayashi Kazunao, Shuji Terai   +9 more
wiley   +1 more source

Ticagrelor: A Reversible P2Y12 Inhibitor in Preventionof Thrombotic Events

RUHS Journal of Health Sciences, 2023
Antiplatelet drugs play a crucial role in patients of coronary artery diseases, cerebrovascular diseases, and maintaining the patency of revascularised arteries and stents after coronary angioplasty.
Uma Advani , Charu Jain , Alka Bansal , Neha Sharma , Kopal Sharma
doaj   +1 more source

Antithrombotic use in retinal artery occlusion: A narrative review

The Kaohsiung Journal of Medical Sciences, Volume 41, Issue 4, April 2025.
Abstract Retinal artery occlusion (RAO) is a critical ophthalmic emergency with a high risk of significant visual impairment. While traditional treatment aims to promptly restore blood flow to the retina, recent research has investigated the potential benefits of anticoagulation therapy for managing this condition. This paper reviews current literature
Wan‐Yu Liu, Yun‐Hsin Tang, Yi‐Hsing Chen   +2 more
wiley   +1 more source